Treatment of hepatorenal syndrome Octreotide vs. Midodrine vs. Norepinephrine as part of triple therapy
Osman Mohamed Osman;
Abstract
Background: hepatorenal syndrome is a serious complication of liver cirrhosis. Splanchnic vasodilatation is the main pathology. Vasoconstrictors are used as treatment aiming at reversal of renal dysfunction.
Methods: thirty patients with hepatorenal syn
Methods: thirty patients with hepatorenal syn
Other data
| Title | Treatment of hepatorenal syndrome Octreotide vs. Midodrine vs. Norepinephrine as part of triple therapy | Other Titles | علاج متلازمة الفشل الكبدي الكلوي مقارنة بين أوكتريوتايد، ميدودرين و نورابينفرين كجزء من العلاج الثلاثي | Authors | Osman Mohamed Osman | Keywords | Treatment of hepatorenal syndrome Octreotide vs. Midodrine vs. Norepinephrine as part of triple therapy | Issue Date | 2012 | Description | Background: hepatorenal syndrome is a serious complication of liver cirrhosis. Splanchnic vasodilatation is the main pathology. Vasoconstrictors are used as treatment aiming at reversal of renal dysfunction. Methods: thirty patients with hepatorenal syn |
Attached Files
| File | Size | Format | |
|---|---|---|---|
| 111271R7272.pdf | 258.12 kB | Adobe PDF | View/Open |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.